Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Nephrologie ; 3(4): 171-5, 1982.
Article in French | MEDLINE | ID: mdl-7155274

ABSTRACT

Hemodialysis has been reported to produce a decrease in cardiac output partially related to a peripheral relocation of blood volume. In order to further evaluate this hypothesis, the hemodynamic effects of dihydroergotamine (DHE), a veino-constrictor drug, were investigated in 5 patients undergoing hemodialysis. Body weight, total blood volume, arterial blood pressure, cardiac output and heart rate were obtained before (period A) and immediately after hemodialysis: before (period B) and after an acute infusion of DHE (period C); studies were performed in supine then in tilted position. During period B, cardiac index decreased by 27% (p less than 0.05) and stroke index by 35% (p less than 0.02). Acute infusion of DHE produced a significant increase in cardiac index (+ 18%, p less than 0.05), stroke index (+ 28%, p less than 0.05) and blood pressure (+ 20%, p less than 0.05). These results indicate that the hemodynamic alterations induced by hemodialysis may be partially reversed by contraction of the capacitance system following DHE infusion.


Subject(s)
Dihydroergotamine/therapeutic use , Hypotension/prevention & control , Renal Dialysis/adverse effects , Veins/drug effects , Adult , Aged , Female , Hemodynamics/drug effects , Humans , Hypotension/etiology , Kidney Failure, Chronic/therapy , Male , Middle Aged
2.
Nephrologie ; 3(4): 152-7, 1982.
Article in French | MEDLINE | ID: mdl-6818483

ABSTRACT

Three women with adenocarcinoma of cardia, adenocarcinoma of liver or ileum carcinoid tumor, respectively, were treated with mitomycin C (MMC) and 5-fluoro-uracil (5-FU). Two patients had renal impairment 6 and 11 months, the third as early as 8 weeks after initiation of MMC therapy. In the three cases, blood transfusions appeared to play an aggravating role inducing respiratory distress, microangiopathic hemolytic anemia and thrombocytopenia, and to accelerate progression of renal failure. Death occurred in the first patient; terminal renal insufficiency necessitated hemodialysis treatment in the second, and after 10 plasma exchanges, renal failure remained stable in the third. Light and electron microscopy study of the kidney revealed renal lesions compatible with thrombotic microangiopathy in all cases. Mesangiolysis with swollen nuclei of endothelial cells in most glomeruli was also seen in two cases. We compared our observations with the findings found in 30 previously reported cases. These observations substantiate the renal toxicity of mitomycin C.


Subject(s)
Kidney Diseases/chemically induced , Mitomycins/adverse effects , Adenocarcinoma/drug therapy , Carcinoid Tumor/drug therapy , Creatinine/blood , Female , Gastrointestinal Neoplasms/drug therapy , Humans , Kidney Glomerulus/ultrastructure , Liver Neoplasms/drug therapy , Middle Aged , Mitomycin
SELECTION OF CITATIONS
SEARCH DETAIL
...